The bottles have a counterfeit foil seal or label and contain an incorrect number of tablets.
Gilead Sciences has issued a warning about tampered and counterfeit versions of two of its HIV products, Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide), a once-daily treatment pill, and Descovy, a PrEP (preexposure prophylaxis) pill that is a combination of emtricitabine and tenofovir alafenamide.
The counterfeit products have been found in pharmacies along with the genuine products. Gilead has notified pharmacies that have been impacted and urged them to only work with distributors authorized by Gilead. A list of authorized distributors can be found here.
Company officials note:
“The safety of individuals taking Gilead medication is always our first priority,” Merdad Parsey, M.D., Ph.D., chief medical officer of Gilead Sciences, said in a statement. “We are taking aggressive action to ensure that healthcare providers and people who rely on our medicines can confidently distinguish authentic Gilead products from counterfeit drugs.”